PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.27%94.051.3%$971.38m
BIIBBiogen Inc.
-0.68%225.631.3%$898.74m
GILDGilead Sciences, Inc.
-0.66%62.840.9%$411.56m
AMGNAmgen Inc.
-2.40%178.101.2%$409.88m
ILMNIllumina, Inc.
-0.01%318.653.5%$277.43m
REGNRegeneron Pharmaceuticals, Inc.
-2.71%333.682.6%$236.01m
VRTXVertex Pharmaceuticals Incorporated
0.68%168.101.9%$221.58m
ONCESpark Therapeutics, Inc.
-0.22%110.4711.2%$169.40m
ALXNAlexion Pharmaceuticals, Inc.
-0.26%125.582.0%$164.91m
EXASExact Sciences Corporation
0.77%92.5225.3%$152.28m
SRPTSarepta Therapeutics, Inc.
-1.50%116.9614.7%$139.27m
AAgilent Technologies, Inc.
0.93%76.131.6%$121.20m
INCYIncyte Corporation
-1.45%73.242.5%$90.62m
IONSIonis Pharmaceuticals, Inc.
0.08%72.738.3%$88.43m
BMRNBioMarin Pharmaceutical Inc.
0.81%83.024.3%$85.32m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.